Source: Annual Congress 2003 - Models and markers of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ortega, C. Martín-Mosquero, M. L. Rubio, G. Peces-Barba, N. González-Mangado (Madrid, Spain). Elastin content in a panacinar emphysema model in rats. Eur Respir J 2003; 22: Suppl. 45, 599

Member's Comments

No comment yet.

Related content which might interest you: Collagen content in human pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001 Different pathology of pulmonary arterioles in centrilobular and panlobular emphysema Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Interleukin-17A in the pathogenesis of elastase-induced emphysema in mice Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012 Evaluation of excited lung gas volume measurements in animals with genetic developing or developed emphysema or with induced panacinar emphysema Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003 Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice Source: Eur Respir J 2004; 24: Suppl. 48, 103s Year: 2004 The effect of interferon-γ on bleomycin-induced alveolitis and pulmonary fibrosis in rats Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 Airflow obstruction is associated with emphysema and fibrosis in the tsk mouse model Source: Eur Respir J 2002; 20: Suppl. 38, 104s Year: 2002 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 Copper content in different tissues of experimental animals with pulmonary emphysema Source: Eur Respir J 2003; 22: Suppl. 45, 80s Year: 2003 Quantitation of hydroxyproline in a mouse model of bleomycin-induced lung fibrosis: comparison with histological analysis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Changes in lung function in a rat model of mild emphysema Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans Year: 2009 Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Effects of NecroX compounds on bleomycin-induced pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Collagen V overexpression correlates with IL-17+ cells in C57BL/6 mice pulmonary remodeling Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Neonatal ßENaC-Tg mice with cystic fibrosis-like lung disease possess enlarged airspaces Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies Year: 2021 The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006